about
Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprinePhysicians' perceptions, attitudes and expectations regarding the role of hospital-based pharmacists in the West Bank, Palestine.Can certain genotypes predispose to poor asthma control in children? A pharmacogenetic study of 9 candidate genes in children with difficult asthma.What the newspapers say about medication adherence: a content analysis.A novel dried blood spot-LCMS method for the quantification of methotrexate polyglutamates as a potential marker for methotrexate use in children.Adherence to treatment in children and adolescents with cystic fibrosis: a cross-sectional, multi-method study investigating the influence of beliefs about treatment and parental depressive symptoms.Pharmacogenetics and the print media: what is the public told?Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study.Population pharmacokinetic model of canrenone after intravenous administration of potassium canrenoate to paediatric patients.Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia.Pharmacokinetics of melatonin in preterm infants.Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant.Population pharmacokinetic and pharmacogenetic analysis of tacrolimus in paediatric liver transplant patients.Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD).Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading?The enantioselective population pharmacokinetics of intravenous ketorolac in children using a stereoselective assay suitable for microanalysis.Potassium canrenoate treatment in paediatric patients: a population pharmacokinetic study using novel dried blood spot sampling.Development and validation of an HPLC method for the rapid and simultaneous determination of 6-mercaptopurine and four of its metabolites in plasma and red blood cells.A simple bioanalytical method for the quantification of antiepileptic drugs in dried blood spots.The pharmacokinetics of intravenous ketorolac in children aged 2 months to 16 years: A population analysis.Children's views on unlicensed/off-label paediatric prescribing and paediatric clinical trials.Adherence to antiepileptic medicines in children: a multiple-methods assessment involving dried blood spot sampling.Perceptions and attitudes of Jordanian paediatricians towards off-label paediatric prescribingProvision of pharmaceutical care by community pharmacists: a comparison across EuropeHealthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trialsExtent and nature of unlicensed and off-label medicine use in hospitalised children in PalestineA multiple methods approach to determine adherence with prescribed mycophenolate in children with kidney transplant
P50
Q33380531-3A9BB93A-1506-4AD2-91A0-F0168730893FQ33455427-FB4374AD-863F-4B4C-8816-25D4EFBFA0DAQ34662042-51F85E71-FCC2-44F0-9F85-2520981863D7Q35006930-CA83BB9B-A627-4147-BD94-C785304A18D1Q35108331-1CCD9391-2A67-493B-81B2-8BFBCDD49C29Q35562254-C9336F38-CBEB-417C-90FE-8F66F6EB832FQ35625803-F0E53588-4B98-4FFF-A044-E2A3497E708EQ36202845-48DE49CF-2AAC-41AC-9BB7-05D4A9B42527Q36390282-C1BC3B95-3C37-435C-A131-D6FE2C1D464EQ37175792-BC303192-31CE-48C9-BE76-52CEA6085447Q37369312-CB65F960-FC76-4D16-BF43-2DE5530D4E84Q37397805-8A58388D-6687-4E9D-AC9C-0C16086E804BQ37492036-6937DC92-C0B3-4B7E-9C04-B7E10414657EQ38000037-4E5F04F6-2247-41FE-9B74-615ADFD73F33Q38648734-26CC008E-9A6F-4CAB-B642-B8ACD445E114Q41063905-D52138CB-1EE3-4F85-9B16-A089E4FB38C7Q43480408-762F2D43-B4F3-4C4B-B4B3-7880419EAC26Q46190954-6B275B61-164B-411D-8D53-28B33B397110Q46503725-221F3C38-D5DF-4AE1-9C7E-02AA29CDEC76Q47218740-BB3EAF6E-CF8F-4E6B-B873-B6F89B15E678Q47579409-534B61AA-988B-48BA-AC09-14A33BF8BD5EQ48508364-C5E86D4C-F286-4EB8-A88A-14F7789A1960Q56775908-BAB9268A-3999-4758-BA24-25B18FFA0FBEQ57413565-3B920E88-4B68-4E3D-ACDB-AB9B90C90990Q83226123-126E41A7-7FEA-4175-8861-F8C725F33214Q84090314-39FEBA7B-8503-451F-8E30-3D7E24080CF4Q92199038-E62542B2-6675-4D79-B015-3C49F2BC3975
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ahmed F Hawwa
@ast
Ahmed F Hawwa
@en
Ahmed F Hawwa
@es
Ahmed F Hawwa
@nl
type
label
Ahmed F Hawwa
@ast
Ahmed F Hawwa
@en
Ahmed F Hawwa
@es
Ahmed F Hawwa
@nl
prefLabel
Ahmed F Hawwa
@ast
Ahmed F Hawwa
@en
Ahmed F Hawwa
@es
Ahmed F Hawwa
@nl
P106
P1153
24780711400
P31
P496
0000-0003-0547-7361